Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 30.6.19971 Min. Lesezeit
Sulzer OrthopedicsRegister, Inc.; Premarket Approval of the Natural Knee and Natural KneeRegister II with Cancellous Structured Titanium (CSTiSUPTM/SUP)
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) is announcing its approval of the application submitted by Sulzer Orthopedics , Inc., Austin, TX, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the Natural Knee and Natural Knee II with Cancellous Structured Titanium (CSTi TM ). After reviewing the recommendation of the Orthopedic and Rehabilitation Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of March 21, 1997, of the approval of the application.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →